22,749 Shares in Bath & Body Works, Inc. $BBWI Acquired by AlphaQuest LLC

AlphaQuest LLC purchased a new position in Bath & Body Works, Inc. (NYSE:BBWI) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 22,749 shares of the company’s stock, valued at approximately $586,000.

A number of other institutional investors also recently bought and sold shares of BBWI. First Horizon Corp purchased a new position in shares of Bath & Body Works during the 3rd quarter valued at $29,000. Stonehage Fleming Financial Services Holdings Ltd bought a new stake in shares of Bath & Body Works during the second quarter valued at approximately $33,000. Geneos Wealth Management Inc. grew its stake in Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares in the last quarter. Carolina Wealth Advisors LLC bought a new stake in Bath & Body Works in the 3rd quarter valued at $54,000. Finally, Parkside Financial Bank & Trust lifted its stake in Bath & Body Works by 24.6% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock worth $55,000 after purchasing an additional 364 shares in the last quarter. Institutional investors own 95.14% of the company’s stock.

Wall Street Analyst Weigh In

BBWI has been the topic of a number of research analyst reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of Bath & Body Works in a research report on Wednesday, January 21st. Zacks Research raised shares of Bath & Body Works from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 20th. Bank of America decreased their price target on shares of Bath & Body Works from $40.00 to $32.00 and set a “buy” rating on the stock in a research note on Thursday, November 20th. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Bath & Body Works in a report on Thursday, January 8th. They issued a “hold” rating and a $21.00 target price on the stock. Finally, Barclays raised their price target on Bath & Body Works from $18.00 to $20.00 and gave the stock an “equal weight” rating in a research report on Tuesday, January 6th. Five equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $23.53.

Insider Activity

In other news, Director Stephen D. Steinour acquired 6,700 shares of the company’s stock in a transaction dated Friday, November 21st. The stock was acquired at an average cost of $14.86 per share, with a total value of $99,562.00. Following the completion of the purchase, the director owned 48,175 shares of the company’s stock, valued at $715,880.50. This represents a 16.15% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Also, Director Francis Hondal bought 3,343 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The shares were acquired at an average cost of $14.99 per share, for a total transaction of $50,111.57. Following the completion of the purchase, the director owned 21,554 shares in the company, valued at $323,094.46. This trade represents a 18.36% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders purchased 33,513 shares of company stock valued at $500,442 over the last three months. 0.26% of the stock is currently owned by company insiders.

Trending Headlines about Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Seeking Alpha published a bullish thesis arguing BBWI is a “double‑digit yield bargain” with turnaround potential; that can attract income/value buyers who see upside if the business execution improves. Bath & Body Works: A Double-Digit Yield Bargain With Significant Turnaround Potential
• Neutral Sentiment: Multiple law firms (Rosen, Schall, Pomerantz, Faruqi, etc.) issued investor alerts reminding purchases during the stated class period and highlighting lead‑plaintiff deadlines (many around March 16, 2026). These notices are informational for shareholders considering participation. BBWI Investors Have Opportunity to Lead Bath & Body Works, Inc. Securities Fraud Lawsuit (PR Newswire)
• Negative Sentiment: Numerous class‑action filings/solicitations (Kessler Topaz, BFA, Levi & Korsinsky, Gross, Bragar Eagel & Squire, etc.) allege securities fraud and promote claims for losses tied to material misstatements/omissions. Such litigation can lead to legal costs, potential settlements, executive distraction, regulatory scrutiny and reputational damage — all risk factors that can pressure BBWI’s share price. Representative filings and notices: Filing Deadline Notice — Kessler Topaz (PR Newswire) BFA Law class action notice (Newsfile) Gross Law Firm notice (GlobeNewswire)

Bath & Body Works Stock Performance

Shares of NYSE BBWI opened at $22.62 on Thursday. The business has a 50-day simple moving average of $20.73 and a two-hundred day simple moving average of $24.53. The company has a market cap of $4.63 billion, a PE ratio of 6.96, a P/E/G ratio of 0.97 and a beta of 1.54. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $41.87.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.40 by ($0.05). The firm had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Bath & Body Works had a net margin of 9.50% and a negative return on equity of 47.35%. The firm’s revenue for the quarter was down 1.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.49 EPS. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. On average, sell-side analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Friday, November 21st were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 3.5%. The ex-dividend date was Friday, November 21st. Bath & Body Works’s dividend payout ratio (DPR) is presently 24.62%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.